Prevalence of metabolic syndrome in an urban population: Tehran Lipid and Glucose Study (Q39654274)

13 September 2017

Prevalence of metabolic syndrome in an urban population: Tehran Lipid and Glucose Study (English)

1 reference

13 September 2017

0 references

0 references

1 reference

1 reference

1

Fereidoun Azizi

1 reference

13 September 2017

Arash Etemadi

3

1 reference

ORCID Public Data File 2021

author name string

Payam Salehi

series ordinal

2

1 reference

PubMed ID

12849921

13 September 2017

Saleh Zahedi-Asl

series ordinal

4

1 reference

13 September 2017

1 July 2003

1 reference

Diabetes Research and Clinical Practice

13 September 2017

1 reference

13 September 2017

61

1 reference

13 September 2017

29-37

1 reference

13 September 2017

1

1 reference

The relationship between serum triglycerides and skinfold thickness in obese subjects

13 September 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2803%2900066-4

7 January 2021

Insulin resistance in hyperglyceridemia

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2803%2900066-4

7 January 2021

Banting lecture 1988. Role of insulin resistance in human disease

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2803%2900066-4

7 January 2021

Invited commentary: insulin resistance syndrome? Syndrome X? Multiple metabolic syndrome? A syndrome at all? Factor analysis reveals patterns in the fabric of correlated metabolic risk factors

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2803%2900066-4

7 January 2021

Hyperinsulinism and dyslipidemias as coronary heart disease risk factors in NIDDM.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2803%2900066-4

7 January 2021

Relation of components of insulin resistance syndrome to coronary disease risk

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2803%2900066-4

7 January 2021

Prevalence of insulin resistance in metabolic disorders: the Bruneck Study.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2803%2900066-4

7 January 2021

Prevalence of the metabolic syndrome in drug-treated hypertensive patients and control subjects

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2803%2900066-4

7 January 2021

Prevalence of the metabolic syndrome among US adults: findings from the third National Health and Nutrition Examination Survey

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2803%2900066-4

7 January 2021

Sex and time trends in cardiovascular disease incidence and mortality: the Framingham Heart Study, 1950-1989.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2803%2900066-4

7 January 2021

Declining rates of coronary heart disease in New Zealand and Australia, 1983-1993.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2803%2900066-4

7 January 2021

Serum lipid levels in an Iranian population of children and adolescents: Tehran lipid and glucose study.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2803%2900066-4

7 January 2021

Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III)

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2803%2900066-4

7 January 2021

Syndrome X and mortality: a population-based study. Risk Factor and Life Expectancy Research Group

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2803%2900066-4

7 January 2021

Cardiovascular morbidity and mortality associated with the metabolic syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2803%2900066-4

7 January 2021

Prevalence and correlates of the insulin resistance syndrome among Native Americans. The Inter-Tribal Heart Project.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2803%2900066-4

7 January 2021

Lipoprotein-cholesterol distributions in selected North American populations: the lipid research clinics program prevalence study

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2803%2900066-4

7 January 2021

Plasma lipids and their interrelationship in Turkish adults

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2803%2900066-4

7 January 2021

Distribution of some risk factors for atherosclerosis in nine Italian population samples. The Research Group ATS-RF2 of the Italian National Research Council

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2803%2900066-4

7 January 2021

Blood lipid concentrations and other cardiovascular risk factors: distribution, prevalence, and detection in Britain

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2803%2900066-4

7 January 2021

Genetic and environmental influences on serum lipid levels in twins.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2803%2900066-4

7 January 2021

Biological and cultural sources of familial resemblance in plasma lipids: A comparison between North America and Israel-the lipid research clinics program

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2803%2900066-4

7 January 2021

Risk factors for coronary heart disease in adult female twins. Genetic heritability and shared environmental influences

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2803%2900066-4

7 January 2021

Serum lipoprotein lipid concentration and composition in homozygous and heterozygous patients with cholesteryl ester transfer protein deficiency

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2803%2900066-4

7 January 2021

The role of hepatic lipase in lipoprotein metabolism and atherosclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2803%2900066-4

7 January 2021

Insulin resistance. A multifaceted syndrome responsible for NIDDM, obesity, hypertension, dyslipidemia, and atherosclerotic cardiovascular disease

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2803%2900066-4

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2803%2900066-4

7 January 2021

Hypertension and associated metabolic abnormalities--the role of insulin resistance and the sympathoadrenal system

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2803%2900066-4

7 January 2021

Visceral adiposity, fasting plasma insulin, and blood pressure in Japanese-Americans.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2803%2900066-4

7 January 2021

Fasting serum insulin levels in essential hypertension. A meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2803%2900066-4

7 January 2021

"Portal" adipose tissue as a generator of risk factors for cardiovascular disease and diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2803%2900066-4

7 January 2021

Neuroendocrine perturbations as a cause of insulin resistance

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2803%2900066-4

7 January 2021

Insulin resistance and insulin secretory dysfunction are independent predictors of worsening of glucose tolerance during each stage of type 2 diabetes development

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2803%2900066-4

7 January 2021

The metabolic syndrome influences the risk of chronic complications in patients with type II diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2803%2900066-4

7 January 2021

10.1016/S0168-8227(03)00066-4

Identifiers

DOI

1 reference

13 September 2017

1 reference

PubMed ID

12849921